Injectable Drug Delivery Technology Market (By Formulation - Liposomes, Microspheres, Nanoparticles, Market By Device Type - Needle Free Injectors, Reusable Needles, Pre-Filled Syringes, Auto Injectors, Disposable Syringes, Pen Needle, Market By Mode Of Delivery - Intravenous, Intraperitoneal, Intramuscular, Subcutaneous, Market By Application- Oncology, Orphan Diseases, Auto-Immune Disease)- Global Industry Size, Share, Trends, and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 0

Introduction

Injection devices deliver the latest generation of drugs directly to the blood stream or to the specific tissues. During last few years there is a significant increase in the demand for the various injectable products as they offer a wide array of benefits such as safety, efficacy, and improve the stability. During last few years, there is a significant development in the injectable drug delivery technology.

Market Dynamics

The global injectable drug delivery technology market is majorly driven by rising prevalence of various chronic disease like cancer, diabetes, immunological disease and others. Increasing demand for the better and convenient route of administration for the medication and increasing government support will fueled the growth of the market. According to the World Health Organization (WHO), in 2014, approximately 422 million people across the globe were suffering from diabetes. Moreover, rising per capita income, rising awareness among the people, and increased the demand for the better treatment have boosted the growth of the market during the forecast period 2018—2026. On the other hand, risk of infection associated to the injection may slow the growth of the market.

Market Classification and Overview

The global injectable drug delivery technology market is segment into stroke type, device type, end-user, and region.

On the basis of formulation, the market is segmented nanoparticles, liposomes, microspheres, and others.

Based on the device type, the market is classified into needle free injectors, reusable needles, pre-filled syringes, auto injectors, pen needle, disposable syringes, and others.

On the basis of mode of delivery, the market is segmented into intraperitoneal, intravenous, intramuscular, subcutaneous, and others.

On the basis of application, the market is segmented into oncology, orphan diseases, auto-immune disease, and others.

Regional Overview

Geographically, the global injectable drug delivery technology market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is expected to hold the major share in the global injectable drug delivery technology market owing increasing prevalence of various types of the medications, rising healthcare spending and increasing prevalence of the various chronic diseases in this region. Additionally, huge government support and presence of well developed economies has fuelled the growth of the market.

Europe accounts for the second leading position in the market followed by Asia Pacific. The major driving factors for the growth of the Europe market are increasing government support, presence of huge patient pool and high healthcare spending. Asia Pacific is the fastest growing region for the injectable drug delivery technology market during the forecast period 2016—2026 owing to presence of rapidly developing economies, increasing spending on research and development and increasing government support. On the other hand, LAMEA is expected to witness the steady growth in near future. The Middle East is expected to hold the major share for the market owing to the well developed healthcare sector and high spending on research and development.

Report Coverage

Market	Injectable Drug Delivery Technology Market
Analysis Period	2015 – 2026
Historic Data	2015 – 2016
Base Year	2017
Forecast Data	2018 – 2026
Market Stratification	Stroke Type, Device Type, End-User, Geography
Regional Scope	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Report Coverage	Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The injectable drug delivery technology market comprises of some of the major players such as Alkermes Inc., Bend Research, Polymer Factory, Genentech Inc., MicroCHIPS, Inc., Presage Bioscience, QLT Inc., BIND Biosciences, Inc., Endocyte, Pearl Therapeutics Inc., and UCB Group.

Market Segmentation

Market By Formulation